News
Researchers tested more than 65,000 patients with more than 30 solid tumor types and found the rate of HER2 positivity was about 3%.
Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests required for an accurate diagnosis.
15d
News Medical on MSNStandard DNA tests miss most cases of NUT carcinomaThe diagnosis of a suspected lung, head, and neck cancer called NUT carcinoma should include additional testing capable of detecting gene fusions that are definitive markers of the disease, according ...
Boster Bio pioneers free antibody validation, revolutionizing IHC services with guaranteed reagent reliability, setting new standards for reproducible research in biotech and pharmaceutical ...
Pleasanton, July 24, 2025 (GLOBE NEWSWIRE) -- Boster Bio pioneers free antibody validation, revolutionizing IHC services with guaranteed reagent reliability, setting new standards for reproducible ...
These establishments in Wayne County were inspected between July 14 and 27, according to Pennsylvania Department of ...
Antibody-drug conjugates are currently being investigated in more than 260 clinical trials.“It’s going to be the next novel ...
An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.
For example, automated immunohistochemistry (IHC) testing has already begun at LUTH-NHIS, enabling timely and accurate diagnoses.
10d
Zacks Investment Research on MSNTempus AI Taps Growing ICI Market With New xM AssayTempus AI, Inc. TEM recently introduced xM for treatment response monitoring (TRM), a liquid biopsy assay. It is designed to detect molecular response to immune-checkpoint inhibitor (ICI) therapy in ...
Agilent Technologies has introduced three new models in its Dako Omnis line of staining instruments, designed to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results